东方财富产品
信息网络传播视听节目许可证：0908328号 经营证券期货业务许可证编号：913101046312860336 违法和不良信息举报:021-61278686 举报邮箱：jubao@eastmoney.com
| 序号 | 股票代码 | 股票名称 | 机构名称 | 变动方向 | 变动股份数(股) | 变动后数量(股) | 变动后持股率 | 公布日期 |
| 351 | 03347 | 泰格医药 | UBS Group AG |
增持 | 160.57万 | 458.88万 | 3.73% | 2022-05-30 |
| 352 | 03347 | 泰格医药 | BlackRock, Inc. |
增持 | 33.86万 | 1128.14万 | 9.16% | 2022-05-27 |
| 353 | 03347 | 泰格医药 | F-J Sands Family I, LLC |
增持 | 34.38万 | 1725.81万 | 14.02% | 2022-05-26 |
| 354 | 03347 | 泰格医药 | UBS Group AG |
增持 | 58.54万 | 293.84万 | 2.39% | 2022-05-26 |
| 355 | 03347 | 泰格医药 | 2017 Eagle Holdings LLC |
增持 | 34.38万 | 1725.81万 | 14.02% | 2022-05-26 |
| 356 | 03347 | 泰格医药 | Sands Family Trust, LLC |
增持 | 34.38万 | 1725.81万 | 14.02% | 2022-05-26 |
| 357 | 03347 | 泰格医药 | Sands Capital Management, LP |
增持 | 34.38万 | 1725.81万 | 14.02% | 2022-05-26 |
| 358 | 03347 | 泰格医药 | Sands Capital Management, LLC |
增持 | 34.38万 | 1725.81万 | 14.02% | 2022-05-26 |
| 359 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
减持 | -5.72万 | 1145.97万 | 9.30% | 2022-05-25 |
| 360 | 03347 | 泰格医药 | UBS Group AG |
减持 | -171.09万 | 229.94万 | 1.87% | 2022-05-23 |
| 361 | 03347 | 泰格医药 | UBS Group AG |
增持 | 122.00万 | 827.50万 | 6.72% | 2022-05-20 |
| 362 | 03347 | 泰格医药 | UBS Group AG |
增持 | 122.00万 | 391.03万 | 3.18% | 2022-05-20 |
| 363 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
增持 | 39.11万 | 1126.06万 | 9.14% | 2022-05-20 |
| 364 | 03347 | 泰格医药 | 2017 Eagle Holdings LLC |
增持 | 39.77万 | 1600.55万 | 13.00% | 2022-05-13 |
| 365 | 03347 | 泰格医药 | Sands Family Trust, LLC |
增持 | 39.77万 | 1600.55万 | 13.00% | 2022-05-13 |
| 366 | 03347 | 泰格医药 | Sands Capital Management, LP |
增持 | 39.77万 | 1600.55万 | 13.00% | 2022-05-13 |
| 367 | 03347 | 泰格医药 | Sands Capital Management, LLC |
增持 | 39.77万 | 1600.55万 | 13.00% | 2022-05-13 |
| 368 | 03347 | 泰格医药 | F-J Sands Family I, LLC |
增持 | 39.77万 | 1600.55万 | 13.00% | 2022-05-13 |
| 369 | 03347 | 泰格医药 | UBS Group AG |
减持 | -31.56万 | 709.59万 | 5.76% | 2022-05-12 |
| 370 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
减持 | -40.21万 | 108.49万 | 0.88% | 2022-05-06 |
| 371 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
减持 | -38.73万 | 1105.14万 | 8.97% | 2022-05-03 |
| 372 | 03347 | 泰格医药 | BlackRock, Inc. |
增持 | 51.33万 | 1028.92万 | 8.36% | 2022-04-29 |
| 373 | 03347 | 泰格医药 | BlackRock, Inc. |
减持 | -38.02万 | 977.80万 | 7.94% | 2022-04-28 |
| 374 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
增持 | 13.58万 | 1110.04万 | 9.01% | 2022-04-27 |
| 375 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
减持 | -8.38万 | 1100.24万 | 8.93% | 2022-04-22 |
| 376 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
增持 | 8.30万 | 1108.62万 | 9.00% | 2022-04-21 |
| 377 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
增持 | 8.30万 | 1108.62万 | 9.00% | 2022-04-21 |
| 378 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
减持 | -11.22万 | 1100.39万 | 8.93% | 2022-04-19 |
| 379 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
增持 | 22.85万 | 1124.89万 | 9.13% | 2022-04-12 |
| 380 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
减持 | -18.95万 | 1100.67万 | 8.93% | 2022-04-04 |
| 381 | 03347 | 泰格医药 | BlackRock, Inc. |
减持 | -63.21万 | 1085.04万 | 8.81% | 2022-04-01 |
| 382 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
增持 | 37.21万 | 1119.62万 | 9.09% | 2022-04-01 |
| 383 | 03347 | 泰格医药 | BlackRock, Inc. |
增持 | 4.61万 | 1110.96万 | 9.02% | 2022-03-29 |
| 384 | 03347 | 泰格医药 | BlackRock, Inc. |
减持 | -14.02万 | 1106.92万 | 8.99% | 2022-03-28 |
| 385 | 03347 | 泰格医药 | UBS Group AG |
减持 | -4.16万 | 858.18万 | 6.97% | 2022-03-28 |
| 386 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
减持 | -34.43万 | 1107.63万 | 8.99% | 2022-03-28 |
| 387 | 03347 | 泰格医药 | UBS Group AG |
减持 | -74.18万 | 315.75万 | 2.56% | 2022-03-25 |
| 388 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
增持 | 36.19万 | 1131.96万 | 9.19% | 2022-03-24 |
| 389 | 03347 | 泰格医药 | UBS Group AG |
增持 | 29.84万 | 872.44万 | 7.09% | 2022-03-24 |
| 390 | 03347 | 泰格医药 | UBS Group AG |
增持 | 9.40万 | 371.71万 | 3.02% | 2022-03-22 |
| 391 | 03347 | 泰格医药 | UBS Group AG |
减持 | -43.62万 | 859.32万 | 6.98% | 2022-03-17 |
| 392 | 03347 | 泰格医药 | UBS Group AG |
增持 | 83.53万 | 321.39万 | 2.61% | 2022-03-17 |
| 393 | 03347 | 泰格医药 | UBS Group AG |
增持 | 60.00万 | 877.87万 | 7.13% | 2022-03-16 |
| 394 | 03347 | 泰格医药 | UBS Group AG |
增持 | 137.83万 | 745.36万 | 6.05% | 2022-03-15 |
| 395 | 03347 | 泰格医药 | JPMorgan Chase & Co. |
增持 | 79.15万 | 1007.21万 | 8.18% | 2022-03-14 |
| 396 | 03347 | 泰格医药 | UBS Group AG |
减持 | -6.20万 | 610.83万 | 4.96% | 2022-03-10 |
| 397 | 03347 | 泰格医药 | Citigroup Inc. |
减持 | -10.31万 | 729.12万 | 5.92% | 2022-03-09 |
| 398 | 03347 | 泰格医药 | UBS Group AG |
增持 | 7.00万 | 620.56万 | 5.04% | 2022-03-09 |
| 399 | 03347 | 泰格医药 | Aggregate of abrdn plc affiliated investment management entities |
增持 | 22.51万 | 873.02万 | 7.09% | 2022-02-17 |
| 400 | 03347 | 泰格医药 | UBS Group AG |
减持 | -6.09万 | 613.54万 | 4.98% | 2022-02-17 |
